Goldline Pharmaceutical IPO GMP

Listed

Goldline Pharmaceutical IPO GMP & Listing Price

SME · ₹43 · BSE SME

Final GMP before listing
₹15+34.9%
19 May, 3:31 pm
IST
Listed at
₹59.75
Listing gain
+39.0%
Day-1 close
₹56.77

GMP vs actual listing

GMP implied
+34.9%
Listed at
₹59.75
Actual
+39.0%

Closed its first day at ₹56.77 (+32.0% on the issue price)

GMP was off by 4.1% on this issue. We publish every miss, not just the hits.

Subscription status

as of 19 May, 3:31 pm
Total840.74x
Issue typeSME
Price₹43
Issue size₹11.61 Cr
Listing atBSE SME
Listing dateTue, 19 May, 2026
BSE code544759

Not in our records for this issue: Sector, Lot size, Min investment, P/E ratio, Registrar.

Goldline Pharmaceutical IPO FAQs

What was the listing price of Goldline Pharmaceutical IPO?

Goldline Pharmaceutical IPO listed at ₹59.75 on Tue, 19 May, 2026, +39.0% against the issue price of ₹43. The last grey market premium before listing was ₹15, which implied ₹58.

What was the GMP of Goldline Pharmaceutical IPO before listing?

The last grey market premium for Goldline Pharmaceutical IPO was ₹15, recorded at 3:31 pm IST on Tue, 19 May, 2026. That implied +34.9% over the ₹43 price. The stock actually listed +39.0%, so GMP was off by 4.1%.

When was Goldline Pharmaceutical IPO allotment and listing?

The allotment date for Goldline Pharmaceutical IPO is not announced yet and the shares listed on Tue, 19 May, 2026 on BSE SME.

GMP is unofficial. Grey market premium is an unregulated, over-the-counter indication with no backing from SEBI, BSE or NSE. It is not a listing-price guarantee and not investment advice. Read the RHP and consult a SEBI-registered adviser before applying.